|
⚲
|
| Keyboard |
| Ruegsegger Frederick J
✚
|
|
|---|---|
| CIK # | 0001428158 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 4 | [0001428158] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Transcept Pharmaceuticals Inc | |
| Ruegsegger Frederick J |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Transcept Pharmaceuticals Inc TSPT
Stock option (right to buy) · derivative
|
2014-10-30 | Disposed to issuer | 158 | ||
|
Transcept Pharmaceuticals Inc TSPT
Stock option (right to buy) · derivative
|
2014-10-30 | Disposed to issuer | 583 | ||
|
Transcept Pharmaceuticals Inc TSPT
Stock option (right to buy) · derivative
|
2014-10-30 | Disposed to issuer | 583 | ||
|
Transcept Pharmaceuticals Inc TSPT
Stock option (right to buy) · derivative
|
2014-10-30 | Disposed to issuer | 833 | ||
|
Transcept Pharmaceuticals Inc TSPT
Stock option (right to buy) · derivative
|
2014-10-30 | Disposed to issuer | 333 | ||
|
Transcept Pharmaceuticals Inc TSPT
Stock option (right to buy) · derivative
|
2014-10-30 | Disposed to issuer | 333 | ||
|
Transcept Pharmaceuticals Inc TSPT
Stock option (right to buy) · derivative
|
2014-10-30 | Disposed to issuer | 1,125 | ||
|
Transcept Pharmaceuticals Inc TSPT
Common Stock Option (right to buy) · derivative
|
2013-01-07 | Grant | 13,500 | $0.00 | |
|
Transcept Pharmaceuticals Inc TSPT
Common Stock (right to buy) · derivative
|
2012-01-24 | Grant | 7,000 | $0.00 |